Answers are grounded in this paper and cite their sources.
Cross-sectional analysis shows increased barriers to medication adherence relate to higher odds of mild cognitive impairment in rural African Americans with hypertension.
Background Mild cognitive impairment (MCI) is frequently undetected and may lead to medication nonadherence. We examined whether more reported barriers to medication adherence could signal the presence of MCI. Objective We developed a count of barriers (0, 1, 2, and ≥3) and determined the independent association between a greater number of barriers and odds of MCI. Setting Rural primary care practices in Alabama and North Carolina. Participants One thousand two hundred seventy-nine participants of the Southeastern Collaboration to Improve Blood Pressure Control trial; all were African Americans with persistently uncontrolled hypertension. Main Measure Presence of mild cognitive impairment (MCI). Results Participants reporting ≥ 2 barriers had 2.40 (95% CI 1.03–5.75) times higher adjusted odds of MCI compared to those reporting none; those reporting ≥ 3 barriers had 3.80 (95% CI 1.74–8.31) higher odds. As the number of barriers increased, odds of MCI increased ( p for trend < 0.001). Conclusion Barriers to medication adherence may signal MCI.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: